#Vertiflex Superion Procedure

[kayvanh123]

What is Vertiflex?

Vertiflex is a minimally invasive treatment option designed to relieve chronic pain associated with lumbar spinal stenosis (LSS). Lumbar spinal stenosis is a condition where the spinal canal narrows, causing pressure on the spinal cord and nerves, leading to pain, numbness, and weakness in the lower back and legs.

What is Vertiflex?

The Vertiflex Procedure, also known as the Vertiflex Superion Interspinous Spacer, involves the placement of a small implant between the spinous processes (the bony projections on the back of the vertebrae) in the lumbar spine. This device is designed to create space and reduce pressure on the affected nerves.

How Does Vertiflex Help Chronic Pain?

Decompression of Nerves:

The Vertiflex device works by lifting and separating the vertebrae, which helps to widen the spinal canal and reduce the compression of nerves. This decompression alleviates the symptoms of pain, numbness, and tingling associated with LSS.

Minimally Invasive:

The procedure is performed through a small incision, typically requiring only local anesthesia and sedation. This minimally invasive approach reduces the risk of complications and promotes faster recovery compared to traditional open spine surgery.

Stability:

Unlike some other treatments that may involve removing bone or tissue, the Vertiflex device maintains the stability of the spine while providing the necessary space for the nerves.

Preservation of Motion:

The Vertiflex implant preserves the natural movement of the spine, allowing patients to maintain their range of motion and flexibility.

Outpatient Procedure:

The Vertiflex procedure can often be performed on an outpatient basis, meaning patients can go home the same day. This convenience reduces the overall disruption to patients’ lives and allows for a quicker return to normal activities.

Benefits of Vertiflex

Effective Pain Relief: Clinical studies have shown that the Vertiflex Procedure can significantly reduce pain and improve function in patients with lumbar spinal stenosis.

Minimized Risks: Because the procedure is minimally invasive, there is a lower risk of infection, blood loss, and other complications compared to traditional spine surgery.

Quick Recovery: Patients typically experience a shorter recovery time and less postoperative pain, enabling them to resume their daily activities sooner.

Long-Lasting Results: Many patients report sustained pain relief and improved quality of life following the Vertiflex Procedure.

Who is a Candidate for Vertiflex?

The Vertiflex Procedure is generally recommended for patients who:

Have been diagnosed with moderate to severe lumbar spinal stenosis.

Experience significant pain and disability that impacts their daily life.

Have not found adequate relief from conservative treatments such as physical therapy, medications, or epidural injections.

Are not candidates for, or prefer to avoid, traditional open spine surgery.

For more information about our clinic, medical professionals, and treatment options, please visit our main website.

[healthcare-market]

Interspinous Spacers Market : Global Forecast Over 2026

Transparency Market Research (TMR) has published a new report titled, ‘Interspinous Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the interspinous spacers market was valued at US$ 63.45 Mn in 2017 and is projected to expand at a high CAGR during the forecast period. Rise in awareness & demand for minimal invasive surgeries, favorable reimbursement policies for interspinous devices, and increase in the geriatric population are expected to augment the global market from 2018 to 2026. The global interspinous spacers market is likely to be driven by increase in incidence of lumber spinal stenosis and innovative product launches.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Rise in Demand for Minimally Invasive Surgeries and Awareness about Spine Disorder Treatments to Propel Market

The global interspinous spacers market is growing at a rapid pace, driven by increase in awareness about treatments for spine related disorders and adoption of minimally invasive surgeries. Acceptance of minimally invasive surgeries by physicians and surgeons creates awareness about the treatment of spinal disorders. Technological advancements in minimally invasive surgical procedures have led to the development of various interspinous process decompression devices. Interspinous spacer placement has lower complication rates than decompression and spinal fusion techniques. Interspinous spacers are widely used in geriatric population, as elderly patients are not comfortable with surgery due to health conditions.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16439

Favorable Reimbursement Scenario Drives Demand for Interspinous Spacers

Strong reimbursement policies for interspinous spacers in developed countries such as the U.S., Australia, New Zealand, the U.K., and Germany have enabled most of the affected patients to opt for effective treatment methods with quality products. These reimbursement policies have significantly driven the revenue for leading global players in the global market. For instance, in November 2015, the Centers for Medicare and Medicaid Services (CMS) included Vertiflex, Inc.’s Superion Interspinous Spacer in the list of approved surgical procedures in ambulatory surgery centers with effect from January 1, 2016. Restructuring of existing reimbursement policies to incorporate and expand the new product range in the reimbursement schemes in most of countries boosts the growth of the global interspinous spacers market.

Enquiry before Buying Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=16439

North America Dominated Global Market

North America dominated the global interspinous spacers market in 2017, owing to high prevalence of lumbar spinal stenosis, technological advancements, rise in adoption of interspinous spacers, investments in research & development, and well-established health care infrastructure. According to research, rise in prevalence of degenerative disc disorders & lumbar spinal stenosis in the geriatric population propels the market in North America. Moreover, 250,000 and 500,000 people in the U.S. are estimated to be affected by symptoms of spinal stenosis. This number indicates that around 1 in 1,000 persons older than 65 and 5 in 1,000 persons older than 50 are affected by spinal stenosis.

Request for Analysis of COVID19 Impact on Buying Interspinous Spacers Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=16439

Increase in Geriatric Population Drives Demand

The geriatric population is at higher risk of developing degenerative disc disorders and lumbar spinal disorder conditions, as these are caused by age-related degeneration and hypertrophy of the invertible disks, ligament flava, and facet joints. Between 20% and 30% of asymptomatic adults older than 60 have imaging evidence of spinal stenosis. A report published by WHO stated that the number of people aged 65 years or older is expected to increase to 2.1 billion by 2050. A population based study in Japan was conducted which revealed that the incidence rate of lumbar spinal stenosis was about 1.7% to 2.2% in the age group 40 to 49, while the incidence rate in the age group 70 to 79 was 10.3% to 11.2%.

Investments in R&D and M&A by Key Players Propel Global Market

Key players dominating the global interspinous spacers market are Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc. These players focus on mergers & acquisitions and are investing in the development of interspinous spacers and making these available to the patient population. Medtronic's R&D efforts are directed toward maintaining or achieving technological leadership in different markets. Moreover, in November 2018, RTI Surgical announced the acquisition of Paradigm Spine to enhance its footprint and expand the product portfolio across regions.

More Trending Reports by Transparency Market Research:

Mobile Hospitals Market The role of mobile hospitals during the COVID-19 pandemic has strengthened the effectiveness of the model for healthcare services on the wheels. Mobile hospitals served to be the medium to reach out to COVID-19 patients that did not have access to medical care at fixed locations.

Surgical Glue Market Traditional wound sealing methods had limits, thus advances in the surgical glue market were largely targeted at resolving those constraints. In addition, owing to surgical glue's advantageous physical and biological characteristics, a growing number of surgeons are employing this method to close incisions.

Veterinary Supplements Market The global veterinary supplements market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 and 2031. eCommerce and Internet sales are assisting veterinary supplement companies in expanding their income prospects. The necessary inclusion of minerals and vitamins in supplements to promote the health and welfare of dogs is becoming widely recognized.

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[paininstituteliworld-blog]

Different Types of Pain Management Services Offered by Top Pain Management Doctors

From experienced and specialist pain management doctors, you will get complete pain management services for all types pain due to accident, joint pain, spinal cord, cancer pain and any kind of other. Different types of pain management services and solutions provided by them include, but not limited to:

·         Back pain Remedy

·         neck pain treatment

·         Neck and Shoulder Pain Relief

·         Complex Regional Pain Syndrome

·         Cancer Pain Management

·         Coolief radiofrequency ablation

·         DRG Stimulation

·         Spinal Cord Stimulation

·         HF10 therapy

·         Mild Procedure

·         VertiFlex Superion InterSpinous Spacer

Schedule an Appointment Now

For getting relief in pain, you have to schedule an appointment to the top Pain management doctors. You have to make a contact as per your requirement, go through the details and leave rest of the work on experts working.

Pain Institute LI is a one stop reliable pain management center offering you complete pain management care and services. A team of professional doctors has been working here with the motive to provide you relief in pain. You have to make a contact as per your requirement, go through the details and leave rest of the work on experts working here.

So, what you are looking for, call pain management doctors now to get complete pain management services.

[myabhijitr]

Interspinous Process Decompression Devices Market - Size, Share,and Analysis 2018–2026

Since recent past, minimally invasive surgical procedures have gained traction resulting in development of various Interspinous Process Decompression Device. The global interspinous process decompression device market is expected to be driven by the new product launches by the market players. For instance, in 2015, Vertiflex, Inc., innovator in minimally invasive intervention for spinal stenosis, received Premarket Approval Application (PMA) order from the U.S. Food and Drug Administration (FDA) for its product, Superion, indicated for moderate lumbar spinal stenosis. The Superion is least invasive motion preserving device in interspinous spacers’ category. In 2015, the implant was successfully implanted in 2,000 patients around the world as a part of study and is expected to be available in the US market during the forecast period.

Get a PDF Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2316

Moreover, in 2014, Exatech launched Octane Elevate, a new lumbar spacer to restore disc height and addressing anatomical conditions. In 2012, Paradigm Spine’s Coflex (previously called Interspinous U) Interlaminar Technology implant was approved by the FDA through the premarket approval process for one- or two-level lumbar stenosis from L1 to L5 producing at least moderate impairment in skeletally mature patients. Moreover, according to Permera Blue cross, the US-based medical insurance company, NL-Prow (by Non-Linear Technologies), Aperius (by Medtronic plc.), and Falena (by Mikai) devices are in trials in Europe.

Increasing incidence of spinal injuries is also expected to boost growth of interspinous process decompression devices market. According to the National Center for Biotechnology Information (NCBI), in 2007, the global incidence of spinal cord injury was estimated to be 170,312 cases, which increased up to 250,000 to 500,000 cases in 2013. Moreover, reimbursement policies are expected to fuel growth of the interspinous process decompression device market. For instance, in 2016, the International Society for the Advancement of Spine Surgery (ISASS) published recommendations and coverage criteria for decompression with interlaminar stabilization. However, lack of national coverage determination handover the policy discretion to local Medicare carriers.

Interspinous process decompression device market is expected to be constrained by limited market players and stringent regulatory scenario for the implantable device. Moreover, high cost of spinal surgical procedures and requirement of professionally trained surgeons are expected to hinder the market growth.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/2316

Abbott Spine, Paradigm spine, Medtronic Plc. and Vertiflex, Inc. are the key players implementing novel inorganic strategies for gaining maximum market shares, in turn strengthening market position. For instance, in 2015, Vertiflex, Inc., introduced two significant reimbursement milestone to broaden their opportunity for Superion (interspinous spacer). The reimbursement includes transition of Category III code to Category I, erasing the longstanding uncertainty associated with coverage and payment involved in category III. Furthermore, Superion based minimally invasive procedure in Ambulatory Surgical Centers will afford Medicare beneficiaries increasing the access. Both reimbursement plans are expected to expand the market opportunity for Superion and in turn increase the company revenues.

[expertofmarketinsights-blog]

Interspinous Process Decompression Devices Market Size & Share to See Modest Growth Through 2026

Interspinous process decompression device also called as interspinous spacer are medical implants used for treatment of spinal stenosis. This devices are intended to reduce the spinal pain via positioning between the vertebrae through minimally invasive surgical procedures. Interspinous process decompression device are one of the types of dynamic stabilization devices used for non-fusion spinal surgery, designed to be permanently implanted between two interspinous processes in lower spine without attaching screws or hardware to the bone or ligaments.

Interspinous Process Decompression Devices Market – Drivers

Since recent past, minimally invasive surgical procedures have gained traction resulting in development of various interspinous process decompression device. The global interspinous process decompression device market is expected to be driven by the new product launches by the market players. For instance, in 2015, Vertiflex, Inc., innovator in minimally invasive intervention for spinal stenosis, received Premarket Approval Application (PMA) order from the U.S. Food and Drug Administration (FDA) for its product, Superion, indicated for moderate lumbar spinal stenosis. The Superion is least invasive motion preserving device in interspinous spacers’ category. In 2015, the implant was successfully implanted in 2,000 patients around the world as a part of study and is expected to be available in the US market during the forecast period.

Moreover, in 2014, Exatech launched Octane Elevate, a new lumbar spacer to restore disc height and addressing anatomical conditions. In 2012, Paradigm Spine’s Coflex (previously called Interspinous U) Interlaminar Technology implant was approved by the FDA through the premarket approval process for one- or two-level lumbar stenosis from L1 to L5 producing at least moderate impairment in skeletally mature patients. Moreover, according to Permera Blue cross, the US-based medical insurance company, NL-Prow (by Non-Linear Technologies), Aperius (by Medtronic plc.), and Falena (by Mikai) devices are in trials in Europe.

Increasing incidence of spinal injuries is also expected to boost growth of interspinous process decompression devices market. According to the National Center for Biotechnology Information (NCBI), in 2007, the global incidence of spinal cord injury was estimated to be 170,312 cases, which increased up to 250,000 to 500,000 cases in 2013. Moreover, reimbursement policies are expected to fuel growth of the interspinous process decompression device market. For instance, in 2016, the International Society for the Advancement of Spine Surgery (ISASS) published recommendations and coverage criteria for decompression with interlaminar stabilization. However, lack of national coverage determination handover the policy discretion to local Medicare carriers.

Interspinous Process Decompression Devices Market - Taxonomy

By Product Type

X-STOP

DIAM

Coflex

Wallis

Others

By Flexibility

Compressible

Non-compressible

By End User

Hospital

Ambulatory Surgical Centers

Interspinous Process Decompression Devices Market – Competitor

Abbott Spine, Paradigm spine, Medtronic Plc. and Vertiflex, Inc. are the key players implementing novel inorganic strategies for gaining maximum market shares, in turn strengthening market position.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/2316

Interspinous Process Decompression Devices Market - Regional Analysis

Based on geography, the interspinous process decompression devices market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. The North American interspinous process decompression device market holds a dominant position attributed to increasing adoption rate for new technologies. Furthermore, Asia Pacific is expected to witness fast growth during forecast period, owing to increasing medical facilities and increasing geriatric pool. For instance, according to Economic and Social Commission for Asia and the Pacific, 2016, between 2015 and 2030, number of people aged 60 years or older are projected to increase in Asia by 66%.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave,  #3200  Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

[chicagoneuropain]

Burning away the Chronic pain: Advantages of Radiofrequency Ablation

Have you ever felt trapped in a world of constant pain? An ache that lingers without warning.

For many, chronic pain is a debilitating condition that can significantly impact their quality of life. Traditional pain management methods may offer temporary relief, but they simply aren't enough. That's where Radiofrequency Ablation comes in.

What is Radiofrequency Ablation?

Radiofrequency ablation, or RFA, is a minimally invasive treatment in which nerve tissue is heated and destroyed using radiofrequency energy. The procedure is of special help for chronic pain emanating from a specific set of nerves in the back or neck area.

This involves the placement of a thin needle in the region of interest in RFA. The needle is attached to a radiofrequency generator, an equipment piece that feeds heat into targeted nerve tissue. Such heat causes the death of nerve tissue and hence impairs the transmission of pain impulses.

How does RFA work?

Identifying the source of pain: A specialized doctor, often referred to as a Radiofrequency Ablation Specialist, uses imaging techniques like X-rays or CT scans to pinpoint the specific nerve causing the pain.

Inserting a needle: A thin needle is inserted into the affected area, guided by the imaging equipment.

Delivering radiofrequency energy: Once the needle is in place, radiofrequency energy is delivered through it. This energy heats the nerve tissue, causing it to be destroyed.

Benefits of Radiofrequency Ablation

Minimally invasive: The procedure of RFA is a lot less invasive as compared to the usual surgeries—often with just a small skin incision.

Quick recovery: Most patients have minimal downtimes after RFA, resuming their day-to-day activities within a relatively short time.

Long-lasting pain relief: For most patients, RFA provides long pain relief and improves their overall quality of life.

Effective for a range of pain conditions: RFA can be applied for a wide variety of chronic pain conditions, such as the following:

Back pain

Neck pain

Facet joint pain

Osteoarthritis pain

Neuropathic pain

Safe and effective treatment modality: RFA is a well-established procedure with a very high success rate and negligible risks.

Who is the ideal candidate for RFA?

People suffering from chronic pain: You could be a good candidate for RFA if one has been suffering from chronic pain, and other treatments are not effective enough.

Patients for Whom Other Treatments Have Been Tried: The RFA procedure is considered for patients who have tried different medications, physical therapy, and other pain management techniques without substantial relief.

General good health: Although RFA is a generally safe procedure, there is a necessity for a person to be in the best general health condition before undergoing RFA.

Radiofrequency Ablation for Back Pain

The final and most common effect could be back pain, which may significantly impact every activity an individual carries out. When all other conservative modes of treatment have been tried, Radiofrequency Ablation for Back Pain is considered

Diagnosis of the origin of the pain in the back: A Radiofrequency Ablation Specialist shall carefully evaluate the symptoms and medical history for identifying the exact nerve causing your backache.

The RFA procedure targets the pain-carrying nerve itself: Inserting a needle in the region of the spine where the affected nerve responsible for pain signal generation lies. Radiofrequency energy stops the pain signals transmitted by the nerves.

Possible benefits of RFA in back pain: It does alleviate lower back pain considerably and thus enables them to go about their activities with a lot less discomfort. It may also help reduce reliance on pain medications.

RFA Procedure specifics for Chronic Pain

RFA for chronic pain is a treatment that can be centered towards the needs of a patient.

Preparation for the test: You will be requested to provide your history and current medications. You may be asked to fast for a certain period of time before the test.

The procedure itself: The RFA is usually performed in an outpatient setting or a clinic. It involves the use of any image guidance to thread a needle at the injured nerve, followed by radiofrequency energy delivery.

Post-procedure care: You might be kept under observation for a short while after the procedure before being sent home. You will also be given thorough instructions on post-procedure care, such as wound care and any further check-ups that may be required.

Pain Management Solutions in Chicago

Radiofrequency Ablation may prove particularly useful if one is searching for Chronic Pain Management Solutions in Chicago.

Experienced specialists: Chronic Pain Management Specialists in Radiofrequency Ablation in Chicago possess extensive experience in providing the best treatment plans to the patients through comprehensive consultations & ongoing support.

Advanced facilities: We are equipped with the latest technological infrastructure to perform such RFA procedures.

Pain management services: Our comprehensive services include pain management, but are not limited to RFA only, we also provide pharmacological treatment, physical therapy, & other interventional procedures for pain.

Conclusion

Chronic pain could drain your energy in day to day life, but RFA promises to be an answer. Minimally invasive, it gives durable pain relief sans heavy surgical burdens and addictive medicines. Consult a Radiofrequency Ablation Specialist today and find out more about this innovative therapy that could help you take back your life.

[chicagoneuropain]

Understanding Spinal Stenosis & Its Innovative Treatment Options

For many people, living with chronic pain has become a reality. At the Chicago Institute for Neuropathic Pain, we are dedicated to diagnosing & treating the root cause of your pain rather than just addressing the symptoms.

One such condition that often results in chronic pain is spinal stenosis. To better understand this condition, its effects, and available treatment options, we've compiled this comprehensive guide. 

Spinal Stenosis

Spinal stenosis is a medical condition characterised by the narrowing of the spaces within your spine. This narrowing can put pressure on the nerves that travel through the spine, often leading to persistent pain, numbness, and weakness in the legs and arms. It commonly affects the neck & the lower back.

Treatment Options for Spinal Stenosis

At the Chicago Institute for Neuropathic Pain, our interventional pain management doctors utilize a variety of innovative treatments to help alleviate the discomfort caused by spinal stenosis. 

Non-Surgical Interventions

Before considering surgery, we typically explore a range of non-surgical interventions that can significantly help manage symptoms. These can include:

Physical Therapy - Strengthening the muscles that support the spine can help alleviate some of the pressure and discomfort associated with spinal stenosis.

Medication - Anti-inflammatory drugs, pain relievers, and in some cases, corticosteroids or nerve pain medications, can be utilized to manage pain and reduce inflammation.

Epidural Injections - This involves injecting a corticosteroid, often combined with a local anaesthetic, into the epidural space of the spine to reduce inflammation and pain.

Minimally Invasive Procedures

When non-surgical interventions are not effective, we offer minimally invasive procedures, which are performed using small incisions, causing less harm to the surrounding tissues, reducing pain, and speeding up recovery. These include:

Nerve Blocks - This procedure involves injecting an anaesthetic directly near the affected nerves, temporarily blocking the pain signal transmitted to the brain.

Radiofrequency Ablation (RFA) - This innovative technique uses heat produced by radio waves to target specific nerves and disrupt their ability to transmit pain signals.

Spinal Cord Stimulation - This involves implanting a small device near the spinal cord to deliver mild electrical impulses, which can help block pain signals from reaching the brain.

Vertiflex Procedure

The Vertiflex procedure, also known as Superion Indirect Decompression System, is a minimally invasive treatment specifically designed for lumbar spinal stenosis. 

During this procedure, a small incision is made in the lower back to insert and deploy the Vertiflex device. The device remains in place, maintaining an optimal height between the vertebrae, and alleviating symptoms by decompressing the spinal canal. 

This procedure typically takes less than an hour and is performed under local anaesthesia, allowing patients to return home the same day.

Aurora ZIP Procedure

The Aurora ZIP procedure is a minimally invasive spinal fusion technique used to treat various spinal conditions, including spinal stenosis.

The procedure involves a small incision in the back where the ZIP device is inserted between the affected vertebrae. Once in place, the device helps stabilize the spine and promotes fusion. This not only reduces pain and discomfort but also maintains the spine's natural anatomy and minimizes tissue damage.

Both the Vertiflex and Aurora ZIP procedures represent advancements in spinal stenosis treatment, offering less invasive alternatives with quicker recovery times compared to traditional surgery. 

[healthcare-market]

Interspinous Spacer Market Set to Record Exponential Growth by 2026

Transparency Market Research (TMR) has published a new report titled, ‘Interspinous Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global interspinous spacers market was valued at US$ 63.45 Mn in 2017 and is projected to expand at a high CAGR during the forecast period. Rise in awareness & demand for minimal invasive surgeries, favorable reimbursement policies for interspinous devices, and increase in the geriatric population are expected to augment the global market from 2018 to 2026. The global interspinous spacers market is likely to be driven by increase in incidence of lumber spinal stenosis and innovative product launches.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Rise in Demand for Minimally Invasive Surgeries and Awareness about Spine Disorder Treatments to Propel Market

The global interspinous spacers market is growing at a rapid pace, driven by increase in awareness about treatments for spine related disorders and adoption of minimally invasive surgeries. Acceptance of minimally invasive surgeries by physicians and surgeons creates awareness about the treatment of spinal disorders. Technological advancements in minimally invasive surgical procedures have led to the development of various interspinous process decompression devices. Interspinous spacer placement has lower complication rates than decompression and spinal fusion techniques. Interspinous spacers are widely used in geriatric population, as elderly patients are not comfortable with surgery due to health conditions.

Request a Sample of Interspinous Spacers Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Favorable Reimbursement Scenario Drives Demand for Interspinous Spacers

Strong reimbursement policies for interspinous spacers in developed countries such as the U.S., Australia, New Zealand, the U.K., and Germany have enabled most of the affected patients to opt for effective treatment methods with quality products. These reimbursement policies have significantly driven the revenue for leading global players in the global market. For instance, in November 2015, the Centers for Medicare and Medicaid Services (CMS) included Vertiflex, Inc.’s Superion Interspinous Spacer in the list of approved surgical procedures in ambulatory surgery centers with effect from January 1, 2016. Restructuring of existing reimbursement policies to incorporate and expand the new product range in the reimbursement schemes in most of countries boosts the growth of the global interspinous spacers market.

Enquiry before Buying Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=16439

North America Dominated Global Market

North America dominated the global interspinous spacers market in 2017, owing to high prevalence of lumbar spinal stenosis, technological advancements, rise in adoption of interspinous spacers, investments in research & development, and well-established health care infrastructure. According to research, rise in prevalence of degenerative disc disorders & lumbar spinal stenosis in the geriatric population propels the market in North America. Moreover, 250,000 and 500,000 people in the U.S. are estimated to be affected by symptoms of spinal stenosis. This number indicates that around 1 in 1,000 persons older than 65 and 5 in 1,000 persons older than 50 are affected by spinal stenosis.

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16439

Increase in Geriatric Population Drives Demand

The geriatric population is at higher risk of developing degenerative disc disorders and lumbar spinal disorder conditions, as these are caused by age-related degeneration and hypertrophy of the invertible disks, ligament flava, and facet joints. Between 20% and 30% of asymptomatic adults older than 60 have imaging evidence of spinal stenosis. A report published by WHO stated that the number of people aged 65 years or older is expected to increase to 2.1 billion by 2050. A population based study in Japan was conducted which revealed that the incidence rate of lumbar spinal stenosis was about 1.7% to 2.2% in the age group 40 to 49, while the incidence rate in the age group 70 to 79 was 10.3% to 11.2%.

Buy now Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=16439&ltype=S

Investments in R&D and M&A by Key Players Propel Global Market

Key players dominating the global interspinous spacers market are Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc. These players focus on mergers & acquisitions and are investing in the development of interspinous spacers and making these available to the patient population. Medtronic's R&D efforts are directed toward maintaining or achieving technological leadership in different markets. Moreover, in November 2018, RTI Surgical announced the acquisition of Paradigm Spine to enhance its footprint and expand the product portfolio across regions.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html

https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[healthcare-market]

Interspinous Spacer Market Growth to be Benefited by Technological Advancements

Transparency Market Research (TMR) has published a new report titled, ‘Interspinous Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global interspinous spacers market was valued at US$ 63.45 Mn in 2017 and is projected to expand at a high CAGR during the forecast period. Rise in awareness & demand for minimal invasive surgeries, favorable reimbursement policies for interspinous devices, and increase in the geriatric population are expected to augment the global market from 2018 to 2026. The global interspinous spacers market is likely to be driven by increase in incidence of lumber spinal stenosis and innovative product launches.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Rise in Demand for Minimally Invasive Surgeries and Awareness about Spine Disorder Treatments to Propel Market

The global interspinous spacers market is growing at a rapid pace, driven by increase in awareness about treatments for spine related disorders and adoption of minimally invasive surgeries. Acceptance of minimally invasive surgeries by physicians and surgeons creates awareness about the treatment of spinal disorders. Technological advancements in minimally invasive surgical procedures have led to the development of various interspinous process decompression devices. Interspinous spacer placement has lower complication rates than decompression and spinal fusion techniques. Interspinous spacers are widely used in geriatric population, as elderly patients are not comfortable with surgery due to health conditions.

Request a Sample of Interspinous Spacers Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Favorable Reimbursement Scenario Drives Demand for Interspinous Spacers

Strong reimbursement policies for interspinous spacers in developed countries such as the U.S., Australia, New Zealand, the U.K., and Germany have enabled most of the affected patients to opt for effective treatment methods with quality products. These reimbursement policies have significantly driven the revenue for leading global players in the global market. For instance, in November 2015, the Centers for Medicare and Medicaid Services (CMS) included Vertiflex, Inc.’s Superion Interspinous Spacer in the list of approved surgical procedures in ambulatory surgery centers with effect from January 1, 2016. Restructuring of existing reimbursement policies to incorporate and expand the new product range in the reimbursement schemes in most of countries boosts the growth of the global interspinous spacers market.

Enquiry before Buying Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=16439

North America Dominated Global Market

North America dominated the global interspinous spacers market in 2017, owing to high prevalence of lumbar spinal stenosis, technological advancements, rise in adoption of interspinous spacers, investments in research & development, and well-established health care infrastructure. According to research, rise in prevalence of degenerative disc disorders & lumbar spinal stenosis in the geriatric population propels the market in North America. Moreover, 250,000 and 500,000 people in the U.S. are estimated to be affected by symptoms of spinal stenosis. This number indicates that around 1 in 1,000 persons older than 65 and 5 in 1,000 persons older than 50 are affected by spinal stenosis.

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16439

Increase in Geriatric Population Drives Demand

The geriatric population is at higher risk of developing degenerative disc disorders and lumbar spinal disorder conditions, as these are caused by age-related degeneration and hypertrophy of the invertible disks, ligament flava, and facet joints. Between 20% and 30% of asymptomatic adults older than 60 have imaging evidence of spinal stenosis. A report published by WHO stated that the number of people aged 65 years or older is expected to increase to 2.1 billion by 2050. A population based study in Japan was conducted which revealed that the incidence rate of lumbar spinal stenosis was about 1.7% to 2.2% in the age group 40 to 49, while the incidence rate in the age group 70 to 79 was 10.3% to 11.2%.

Buy now Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=16439&ltype=S

Investments in R&D and M&A by Key Players Propel Global Market

Key players dominating the global interspinous spacers market are Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc. These players focus on mergers & acquisitions and are investing in the development of interspinous spacers and making these available to the patient population. Medtronic's R&D efforts are directed toward maintaining or achieving technological leadership in different markets. Moreover, in November 2018, RTI Surgical announced the acquisition of Paradigm Spine to enhance its footprint and expand the product portfolio across regions.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html

https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[healthcare-market]

Interspinous Spacers Market Status and Forecast, by Players, Types and Applications

Transparency Market Research (TMR) has published a new report titled, ‘Interspinous Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global interspinous spacers market was valued at US$ 63.45 Mn in 2017 and is projected to expand at a high CAGR during the forecast period. Rise in awareness & demand for minimal invasive surgeries, favorable reimbursement policies for interspinous devices, and increase in the geriatric population are expected to augment the global market from 2018 to 2026. The global interspinous spacers market is likely to be driven by increase in incidence of lumber spinal stenosis and innovative product launches.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Rise in Demand for Minimally Invasive Surgeries and Awareness about Spine Disorder Treatments to Propel Market

The global interspinous spacers market is growing at a rapid pace, driven by increase in awareness about treatments for spine related disorders and adoption of minimally invasive surgeries. Acceptance of minimally invasive surgeries by physicians and surgeons creates awareness about the treatment of spinal disorders. Technological advancements in minimally invasive surgical procedures have led to the development of various interspinous process decompression devices. Interspinous spacer placement has lower complication rates than decompression and spinal fusion techniques. Interspinous spacers are widely used in geriatric population, as elderly patients are not comfortable with surgery due to health conditions.

Request a Sample of Interspinous Spacers Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Favorable Reimbursement Scenario Drives Demand for Interspinous Spacers

Strong reimbursement policies for interspinous spacers in developed countries such as the U.S., Australia, New Zealand, the U.K., and Germany have enabled most of the affected patients to opt for effective treatment methods with quality products. These reimbursement policies have significantly driven the revenue for leading global players in the global market. For instance, in November 2015, the Centers for Medicare and Medicaid Services (CMS) included Vertiflex, Inc.’s Superion Interspinous Spacer in the list of approved surgical procedures in ambulatory surgery centers with effect from January 1, 2016. Restructuring of existing reimbursement policies to incorporate and expand the new product range in the reimbursement schemes in most of countries boosts the growth of the global interspinous spacers market.

Enquiry before Buying Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=16439

North America Dominated Global Market

North America dominated the global interspinous spacers market in 2017, owing to high prevalence of lumbar spinal stenosis, technological advancements, rise in adoption of interspinous spacers, investments in research & development, and well-established health care infrastructure. According to research, rise in prevalence of degenerative disc disorders & lumbar spinal stenosis in the geriatric population propels the market in North America. Moreover, 250,000 and 500,000 people in the U.S. are estimated to be affected by symptoms of spinal stenosis. This number indicates that around 1 in 1,000 persons older than 65 and 5 in 1,000 persons older than 50 are affected by spinal stenosis.

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16439

Increase in Geriatric Population Drives Demand

The geriatric population is at higher risk of developing degenerative disc disorders and lumbar spinal disorder conditions, as these are caused by age-related degeneration and hypertrophy of the invertible disks, ligament flava, and facet joints. Between 20% and 30% of asymptomatic adults older than 60 have imaging evidence of spinal stenosis. A report published by WHO stated that the number of people aged 65 years or older is expected to increase to 2.1 billion by 2050. A population based study in Japan was conducted which revealed that the incidence rate of lumbar spinal stenosis was about 1.7% to 2.2% in the age group 40 to 49, while the incidence rate in the age group 70 to 79 was 10.3% to 11.2%.

Buy now Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=16439&ltype=S

Investments in R&D and M&A by Key Players Propel Global Market

Key players dominating the global interspinous spacers market are Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc. These players focus on mergers & acquisitions and are investing in the development of interspinous spacers and making these available to the patient population. Medtronic's R&D efforts are directed toward maintaining or achieving technological leadership in different markets. Moreover, in November 2018, RTI Surgical announced the acquisition of Paradigm Spine to enhance its footprint and expand the product portfolio across regions.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html

https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research, 90 Sate Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/

[healthcare-market]

Interspinous Spacers Market Size, Share, Growth Trends, and Forecast Analysis

Transparency Market Research (TMR) has published a new report titled, ‘Interspinous Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global interspinous spacers market was valued at US$ 63.45 Mn in 2017 and is projected to expand at a high CAGR during the forecast period. Rise in awareness & demand for minimal invasive surgeries, favorable reimbursement policies for interspinous devices, and increase in the geriatric population are expected to augment the global market from 2018 to 2026. The global interspinous spacers market is likely to be driven by increase in incidence of lumber spinal stenosis and innovative product launches.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Rise in Demand for Minimally Invasive Surgeries and Awareness about Spine Disorder Treatments to Propel Market

The global interspinous spacers market is growing at a rapid pace, driven by increase in awareness about treatments for spine related disorders and adoption of minimally invasive surgeries. Acceptance of minimally invasive surgeries by physicians and surgeons creates awareness about the treatment of spinal disorders. Technological advancements in minimally invasive surgical procedures have led to the development of various interspinous process decompression devices. Interspinous spacer placement has lower complication rates than decompression and spinal fusion techniques. Interspinous spacers are widely used in geriatric population, as elderly patients are not comfortable with surgery due to health conditions.

Request a Sample of Interspinous Spacers Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16439

Favorable Reimbursement Scenario Drives Demand for Interspinous Spacers

Strong reimbursement policies for interspinous spacers in developed countries such as the U.S., Australia, New Zealand, the U.K., and Germany have enabled most of the affected patients to opt for effective treatment methods with quality products. These reimbursement policies have significantly driven the revenue for leading global players in the global market. For instance, in November 2015, the Centers for Medicare and Medicaid Services (CMS) included Vertiflex, Inc.’s Superion Interspinous Spacer in the list of approved surgical procedures in ambulatory surgery centers with effect from January 1, 2016. Restructuring of existing reimbursement policies to incorporate and expand the new product range in the reimbursement schemes in most of countries boosts the growth of the global interspinous spacers market.

Enquiry Before Buying Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=16439

North America Dominated Global Market

North America dominated the global interspinous spacers market in 2017, owing to high prevalence of lumbar spinal stenosis, technological advancements, rise in adoption of interspinous spacers, investments in research & development, and well-established health care infrastructure. According to research, rise in prevalence of degenerative disc disorders & lumbar spinal stenosis in the geriatric population propels the market in North America. Moreover, 250,000 and 500,000 people in the U.S. are estimated to be affected by symptoms of spinal stenosis. This number indicates that around 1 in 1,000 persons older than 65 and 5 in 1,000 persons older than 50 are affected by spinal stenosis.

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16439

Increase in Geriatric Population Drives Demand

The geriatric population is at higher risk of developing degenerative disc disorders and lumbar spinal disorder conditions, as these are caused by age-related degeneration and hypertrophy of the invertible disks, ligament flava, and facet joints. Between 20% and 30% of asymptomatic adults older than 60 have imaging evidence of spinal stenosis. A report published by WHO stated that the number of people aged 65 years or older is expected to increase to 2.1 billion by 2050. A population based study in Japan was conducted which revealed that the incidence rate of lumbar spinal stenosis was about 1.7% to 2.2% in the age group 40 to 49, while the incidence rate in the age group 70 to 79 was 10.3% to 11.2%.

Pre-Book Interspinous Spacers Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=16439&ltype=S

Investments in R&D and M&A by Key Players Propel Global Market

Key players dominating the global interspinous spacers market are Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc. These players focus on mergers & acquisitions and are investing in the development of interspinous spacers and making these available to the patient population. Medtronic's R&D efforts are directed toward maintaining or achieving technological leadership in different markets. Moreover, in November 2018, RTI Surgical announced the acquisition of Paradigm Spine to enhance its footprint and expand the product portfolio across regions.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research, 90 Sate Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/